Further pharmacological characterization of the adenosine receptor subtype mediating inhibition of oxidative burst in human isolated neutrophils

Drug Development Research

Volumn 43, Issue 4, 1998, Pages 214-224

  Hannon, J P ^a   Bray French, K M ^a,b   Phillips, R M ^a   Fozard, J R ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b RCC Ltd   (Switzerland)

Author keywords

A1, A2, A3 adenosine receptors; Adenosine receptor agonists; Adenosine receptor antagonists; fMLP induced oxidative burst; Human neutrophils

Indexed keywords

ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; CYCLIC AMP; FORMYLMETHIONYLLEUCYLPHENYLALANINE; SUPEROXIDE;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; RESPIRATORY BURST;

EID: 0031818111     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199804)43:4<214::AID-DDR5>3.0.CO;2-L     Document Type: Article

References (58)

1. 3 receptors in rat brain. Mol Pharmacol 48:1038-1045.
2. Alexander SPK Peters JA (1997): Receptor and ion channel nomenclature supplement, adenosine receptors. Trends Pharmacol Sci 8:7-8.
3. 2B4) cells. Br J Pharmacol 119:1286-1290.
4. 2 agonists. Br J Pharmacol 113:111P.
5. Arunlakshana O, Schild HO (1959): Some quantitative uses of drug antagonists. Br J Phamacol Chemother 14:48-58.
6. Bouma MG, Stad RK, Van Den Wildenberg F, Burman WA (1994): Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 153:4159-4168.
7. 3 receptors. J Immunol 158:5400-5408.
8. 2B adenosine receptor in NIH 3T3 fibroblasts. Biochem Pharmacol 47:801-814.
9. 3H]NECA in rat striatal membranes. Mol Pharmacol 29:331-346.
10. 1-selective adenosine antagonist 8-cyclopentyl-1-3-dipropylxanthine to rat brain membranes. Naunyn Schmiedeberg Arch Pharmacol 335:59-63.
11. 2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes. J Immunol 155:2579-2586.
12. Cronstein BN, Kramer SB, Weissman G, Hirschhorn R (1983): Adenosine: A physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 158:1160-1177.
13. 2 receptor on human neutrophils. J Immunol 135:1366-1371.
14. Cronstein BN, Kramer SB, Rosenstein ED, Korchak HM, Weissman G, Hirschhorn R (1988): Occupancy of adenosine receptors raises cyclic AMP alone and in synergy with occupancy of chemoattractant receptors and inhibits membrane depolarization. Biochem J 252:709-715.
15. 2 generation, respectively. J Clin Invest 85:1150-1157.
16. 2 receptors. J Immunol 148:2201-2206.
17. 2-adenosine receptors. J Med Chem 28:487-492.
18. 2+. Biochem J 224:629-635.
19. Dianzani C, Brunelleschi S, Viano I, Fantozzi R (1994): Adenosine modulation of primed human neutrophils. Eur J Pharmacol 263:223-226.
20. 1 receptors in mammalian brain: Species differences in their interactions with agonists and antagonists. Drug Dev Res 9:85-93.
21. Fredholin BB, Abbracchio NT, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994): Nomenclature and classification of purinoceptors: A report from the IUPHAR subcommittee. Pharmacol Rev 46:143-156.
22. 2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phf-stimulated respiratory burst in neutrophil leucocytes. Naunyn Schmiedeberg Arch Pharmacol 354:262-267.
23. Furchgott RF (1972): The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In Blascbko K, Muscholl E (eds): Catecholamines. Heidelberg: Springer-Verlag, pp 283-335.
24. Grishani MB, Hernandez LA, Granger DN (1989): Adenosine inhibits ischemia-reperfusion-induced leukocyte adherence and extravasation. Am J Physiol 257:H1334-H1339.
25. Gurden NW, Coates J, Ellis F, Evans B, Foster K Hornby E, Kennedy I, Martin DP, Strong P, Vardy GJ, Wheeldon A (1993): Functional characterisation of three adenosine receptor types. Br J Pharmacol 109:693-698.
26. 2 cell-surface adenosine receptor. Cell Immunol 159:85-93.
27. 2 receptors. Fed Proc 44:580.
28. Iannone MA, Wollberg G, Zimmerman TP (1989): Chemotactic peptide induces cAMP elevation in human neutropils by amplification of the adenylate cyclase response to endogenously produced adenosine. J Biol Chem 264:20177-20180.
29. Jacobson KA (1996): Specific ligands for the adenosine receptor family. RBI Neurotransmissions XII(1):1-6.
30. 2 receptors in rat brain. J Pharmacol Exp Ther 251:888-893.
31. 2A adenosine receptors are required for ligand recognition. Mol Pharmacol 50:512-521.
32. 3 adenosine receptors. J Med Chem 37:3614-3621.
33. 3 adenosine receptors on human eosinophils elevates intracellular calcium. Blood 9:3569-3574.
34. 3 receptors: Pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 15:298-306.
35. Londos C, Cooper DMF, Wolff J (1980): Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 77:2551-2554.
36. 3 receptor. Cancer Res 54:3521-3526.
37. 3H]Adenosine binding to rat mast cells - Pharmacologic and functional characterisation. Agents Actions 16:453-461.
38. 3 receptors on macrophages inhibits tumor necrosis factor-α. Eur J Pharmacol 310:209-216.
39. Mukherjee G, Quinn MT, Linner JG, Jesaitis AJ (1994): Remodeling of the plasma membrane after stimulation of neutrophils with f-Met-Leu-Phe and dihydrocytocbalasin B: Identification of membrane subdomains containing NADPH oxidase activity. J Leukoc Biol 55:685-694.
40. Müller K, Weingarten R, Ransnas LA, Bokoch GK, Skiai LA (1991): Differential amplification of antagonistic receptor pathways in neutrophils. J Biol Chem 266:12939-12943.
41. 2 receptor. Naunyn Schmiedebergs Arch Pharmacol 346:234-237.
42. 3 adenosine receptor. Mol Pharmacol 45:978-982.
43. 2A receptors. Trends Pharmacol Sci 17:364-372.
44. 2A adenosine receptor. Mol Pharmacol 48:970-974.
45. Peachell PT, Lichtenstein LK, Scheimer RP (1991): Regulation of human basophil and lung mast cell function by adenosine. J Pharmacol Exp Ther 256:717-726.
46. 2A selective adenosine receptor antagonist. Br J Pharmacol 115:1096-1102.
47. 2B receptor and a xanthine-resistant site. Eur J Pharmacol 323:103-106.
48. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268:16887-16890.
49. Richter J (1992): Effect of adenosine analogues and cAMP-raising agents on TNF-, GM-CSF-, and chemotactic peptide-induced degranulation in single adherent neutrophils. J Leukoc Biol 51:270-275.
50. Rose FR, Hirschhorn R, Weissman G, Cronstein BN (1988): Adenosine promotes neutrophil chemotaxis. J Exp Med 167:1186-1194.
51. 3 adenosine receptors. J Immunol 156:3435-3442.
52. Salmon JE, Cronstein BN (1990): Fcγ-receptor-mediated functions in neutrophils are modulated by adenosine receptor occupancy. J Immunol 145:2235-2240.
53. 3 adenosine receptor. Proc Natl Acad Sci USA 90:10365-10369.
54. Schrier DJ, Imre KM (1986): The effects of adenosine agonists on human neutrophil function. J Immunol 137:3284-3289.
55. Sullivan G, Linden J, Hewlett E, Carper K, Hylon J, Mandell G (1990): Adenosine and related compounds counteract tumor necrosis factor-alpha inhibition of neutrophil migration: Implication of a novel cyclic AMP-independent action on the cell surface. J Immunol 145:1537-1544.
56. 3H]CGS 21680 to human and rat brain: Evidence for multiple affinity sites. J Neurochem 55:1763-1771.
57. 2 receptors, adenosine inhibits the upregulation of Mac-1 (CD11b/CD18) expression on fMLP-stitnulated neutrophils. Am J Resp Cell Mol Biol 9:179-185.
58. 3 adenosine receptor. Proc Natl Acad Sci USA 89:7432-7436.